Abstract
exposure assessment on particulate matter (Han X, 2006), several respiratory outcomes have been associated with air pollution exposure in children. Since lung development continues through adolescence and because of higher minute ventilation and higher levels of physical activity, children are more vulnerable to the adverse effects of air pollution than are adults. The respiratory effects of air pollution can be divided into three major areas: respiratory symptomatology and disease, pulmonary function and airway reactivity. Some contaminants (e.g., benzene, carbon dioxide, carbon monoxide, lead, nitrogen oxide, particulate matter and sulfur dioxide) can cause cancer, birth defects, brain and nerve damage and long term injury to the lungs and airway passages. When certain concentrations and durations are exceeded, these can cause severe injury and even death. Respiratory symptoms associated with air pollution exposure in children include burning eyes and nose, recurrent colds, itchy irritated throat, chronic cough and difficulty breathing. Also noted is increased prevalence of chest wheezing apart from colds or of wheezing most days or nights, of chest tightness, and of cough/phlegm production requiring medical attention. Air pollution is also associated with increased incidence of chest illness and of acute upper and lower respiratory tract infections. Furthermore, increased frequency of symptomatic asthmatic attacks, of exacerbations in persons with chronic cardiopulmonary or other disease, of emergency ward or physician visits, and increased frequency and duration of hospitalization for respiratory conditions have been observed. A meta-analysis showed 1.8 times risk of pneumonia in young children due to exposure to unprocessed solid fuel (Dherani M, 2008). Reductions in pulmonary function such as FEV1 or FVC associated with clinical symptoms have been reported with air pollution. Children may fail to maintain their predicted FEV1 growth curve. Further associations include increase in use of asthma medication and enhanced bronchial reactivity (AAP, 2004; ATS, 2000; Ackermann-Liebrich U, 1992; Braun-Fahrlander C,
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.